The University of Chicago Header Logo

Connection

Stephen Hanauer to Biological Therapy

Back to Details
This is a "connection" page, showing publications Stephen Hanauer has written about Biological Therapy.
Stephen Hanauer
Connection Strength
3.632
Biological Therapy
  1. Early vs Late Use of Anti-TNFa Therapy in Adult Patients With Crohn Disease: A Systematic Review and Meta-Analysis. Inflamm Bowel Dis. 2020 11 19; 26(12):1808-1818.
    View in: PubMed
    Score: 0.716
  2. Balancing the risks and benefits of biologic therapy in inflammatory bowel diseases. Expert Opin Drug Saf. 2015; 14(12):1915-34.
    View in: PubMed
    Score: 0.506
  3. Assessing response and loss of response to biological therapies in IBD. Am J Gastroenterol. 2011 Apr; 106(4):685-98.
    View in: PubMed
    Score: 0.366
  4. The expanding role of biologic therapy for IBD. Nat Rev Gastroenterol Hepatol. 2010 Feb; 7(2):63-4.
    View in: PubMed
    Score: 0.339
  5. Positioning biologic agents in the treatment of Crohn's disease. Inflamm Bowel Dis. 2009 Oct; 15(10):1570-82.
    View in: PubMed
    Score: 0.331
  6. The ethics of phase I trials of biologic agents. Nat Clin Pract Gastroenterol Hepatol. 2008 Oct; 5(10):533.
    View in: PubMed
    Score: 0.309
  7. Emerging biologic therapies in inflammatory bowel disease. Rev Gastroenterol Disord. 2004; 4(2):66-85.
    View in: PubMed
    Score: 0.222
  8. Perspectives of Clinicians in the United States and Europe on Monitoring Levels of Biologic Agents in Patients Receiving Biologic Therapies for Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2019 08; 17(9):1718-1723.
    View in: PubMed
    Score: 0.162
  9. Too Soon to Discard 5-ASAs? Am J Gastroenterol. 2019 03; 114(3):534-535.
    View in: PubMed
    Score: 0.159
  10. Interpreting Registrational Clinical Trials of Biological Therapies in Adults with Inflammatory Bowel Diseases. Inflamm Bowel Dis. 2016 11; 22(11):2711-2723.
    View in: PubMed
    Score: 0.135
  11. Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol. 2011 Apr; 106(4):644-59, quiz 660.
    View in: PubMed
    Score: 0.091
  12. Review article: evolving concepts in treatment and disease modification in ulcerative colitis. Aliment Pharmacol Ther. 2008 Mar; 27 Suppl 1:15-21.
    View in: PubMed
    Score: 0.074
  13. Top-down versus step-up approaches to chronic inflammatory bowel disease: presumed innocent or presumed guilty. Nat Clin Pract Gastroenterol Hepatol. 2005 Nov; 2(11):493.
    View in: PubMed
    Score: 0.063
  14. Medical therapy for ulcerative colitis 2004. Gastroenterology. 2004 May; 126(6):1582-92.
    View in: PubMed
    Score: 0.057
  15. Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: overview of randomized clinical studies. Rev Gastroenterol Disord. 2004; 4 Suppl 3:S18-24.
    View in: PubMed
    Score: 0.056
  16. Update on medical management of inflammatory bowel disease: ulcerative colitis. Rev Gastroenterol Disord. 2001; 1(4):169-76.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.